Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01360216 · ClinicalTrials.gov registry record · NA
Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 1,500
- Enrollment target
NCT01360216 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 1,500 participants.
The verdict
NCT01360216, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,500 participants
- Enrollment target
Study Summary
The purpose of the study is to measure whether an education and training intervention for clinicians and contraceptive counselors on long-acting reversible contraception (LARC) will result in greater use of the methods among contraceptive patients.
Interventions
- BEHAVIORAL LARC education and training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2011-05 |
| Est. Completion | 2013-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01360216
The ClinicalTrials.gov registry entry for NCT01360216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LARC education and training is the first listed.
NCT01360216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01360216 about?
NCT01360216 is a clinical study titled "Cluster, Randomized Trial on Long Acting Reversible Contraception (LARC) Education and Training". The purpose of the study is to measure whether an education and training intervention for clinicians and contraceptive counselors on long-acting reversible contraception (LARC) will result in greater use of the methods among contraceptive patients.
What is the current status of trial NCT01360216?
This trial is currently completed. It is a NA study. The enrollment target is 1,500 participants. The study started on 2011-05. Estimated completion is 2013-08.
What interventions are being tested in trial NCT01360216?
The interventions under investigation include: LARC education and training (BEHAVIORAL).
Who is sponsoring clinical trial NCT01360216?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.